Skip to content

Clinical trials

Pulmonary Arterial Hypertension trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Country / region: Canada Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20063
20071
20085
20095
20105
20115
20127
20131
20142
20152
20166
20174
20185
20196
20203
20218
20222
20232
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated20
Recruiting6
Active, not recruiting4
Unknown status4
Withdrawn3
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion14
United Therapeutics8
Laval University6
Bayer5
Bellerophon Pulse Technologies4
Merck Sharp & Dohme LLC4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Gilead Sciences3
Novartis Pharmaceuticals3
Aerovate Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension85
Hypertension, Pulmonary31
Hypertension7
Heart Failure3
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hemophilia A2
Hyperaldosteronism2

Trials

Showing 26 to 50 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.